Dr. Srikant M. Datar, Ph.D., is Independent Director of Stryker Corporationration, since July 29, 2009. He serves at Arthur Lowes Dickinson Professor at the Graduate School of Business Administration of Harvard University since 1996 and Senior Associate Dean from 2001 to 2010. Prior to 1996, he was Professor, Accounting and Management, since 1989 at Stanford University. He is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc. a management, technology and policy consulting firm and KPIT Cummins Infosystems Ltd., a global IT consulting and product engineering partner company.
Age: 59 Director Since 2009
The company has Return on Asset of 8.43 % which means that on every $100 spent on asset it made $8.43 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.2 % implying that it generated $15.2 on every 100 dollars invested.
The company has 2.77 B in debt with debt to equity (D/E) ratio of 0.33 which is OK given its current industry classification. Stryker Corporation has Current Ratio of 4.57 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
Entity SummaryStryker Corporationration, a medical technology company, offer reconstructive, medical and surgical, and neurotechnology and spine solutions for doctors, hospitals, and other healthcare facilities. Stryker Corporation [SYK] is traded on New York Stock Exchange in USA. It is located in Kalamazoo, MI and employs 22,010 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| SYK NYSE
Stryker Corporation has less than 12.5 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Stryker price boundaries
Promote Stryker and Srikant Datar